Nexgel (NASDAQ:NXGL) specializes in the development and manufacturing of high-water-content, electron-beam cross-linked hydrogels used in medical applications such as wound care, electrode, therapy packs, cosmetics, and transdermal drug delivery systems. With an emphasis on innovation and quality, Nexgel is on a mission to enhance healthcare outcomes and consumer comfort by leveraging its unique hydrogel technology. Their projects span across developing advanced wound care solutions that promote faster healing to creating innovative cosmetic patches that offer superior skin benefits. Objectively, Nexgel aims to expand its product portfolio, enter new markets, and forge strategic partnerships to broaden its impact in healthcare and consumer products sectors. Through continuous research and development, Nexgel is committed to delivering cutting-edge products that meet the evolving needs of its customers.